{
    "Trade/Device Name(s)": [
        "SeraQuest HSV Type 1 Specific IgG"
    ],
    "Submitter Information": "Quest International, Inc.",
    "510(k) Number": "K162276",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ"
    ],
    "Summary Letter Date": "August 10, 2016",
    "Summary Letter Received Date": "August 12, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "immunology",
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "IgG antibody to herpes simplex virus type 1 (HSV-1)"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "ELISA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for SeraQuest HSV Type 1 Specific IgG ELISA for qualitative detection of human IgG antibodies to HSV-1 in serum",
    "Indications for Use Summary": "Intended for qualitative detection of human IgG antibodies to HSV-1 in serum as an aid in presumptive diagnosis of HSV-1 infection in sexually active individuals and expectant mothers; not cleared for blood or plasma donor screening or for matrices other than human serum",
    "fda_folder": "Microbiology"
}